Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 801,695 | 684,778 | 386,349 | 128,455 | 792,739 |
| Depreciation Amortization | 1,885,296 | 1,391,276 | 968,631 | 556,359 | 1,896,158 |
| Income taxes - deferred | -78,638 | -131,034 | -97,488 | -48,167 | -132,202 |
| Accounts receivable | -79,510 | -109,031 | -606,929 | -600,089 | -164,341 |
| Accounts payable and accrued liabilities | -49,993 | -26,261 | 2,182 | -15,521 | -11,803 |
| Other Working Capital | 480,791 | 249,713 | -330,865 | -456,896 | 607,469 |
| Other Operating Activity | -377,596 | -350,177 | 291,663 | 574,078 | -142,870 |
| Operating Cash Flow | $2,582,046 | $1,709,264 | $613,543 | $138,218 | $2,845,151 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -741,514 | -497,200 | -304,333 | -140,592 | -723,472 |
| Net Acquisitions | 656,492 | 531,726 | 533,297 | 44,057 | 148,274 |
| Purchase Of Investment | -88,192 | -71,022 | -529 | -204 | -110,788 |
| Sale Of Investment | 81,303 | 74,163 | 45,299 | 22,513 | 96,969 |
| Investing Cash Flow | $-91,913 | $37,667 | $273,734 | $-74,226 | $-589,017 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 91,775 | 200,443 | 207,283 | 12,491 | 70,714 |
| Debt Issued | 66,563 | 44,381 | 26,772 | 10,084 | 452,268 |
| Debt Repayment | -902,971 | -274,595 | -248,794 | -17,854 | -758,328 |
| Dividend Paid | -717,273 | -580,394 | -470,477 | -61,829 | -694,824 |
| Other Financing Activity | -1,318,334 | -1,153,719 | -728,482 | -257,373 | -1,081,317 |
| Financing Cash Flow | $-2,780,240 | $-1,763,885 | $-1,213,699 | $-314,481 | $-2,011,486 |
| Exchange Rate Effect | 28,349 | -27,045 | -13,175 | -4,901 | -78,583 |
| Beginning Cash Position | 1,544,400 | 1,569,377 | 1,536,979 | 1,549,538 | 1,378,620 |
| End Cash Position | 1,282,643 | 1,525,378 | 1,197,382 | 1,294,149 | 1,544,686 |
| Net Cash Flow | $-261,757 | $-43,998 | $-339,596 | $-255,389 | $166,066 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,582,046 | 1,709,264 | 613,543 | 138,218 | 2,845,151 |
| Capital Expenditure | -756,775 | -504,351 | -315,873 | -145,375 | -740,938 |
| Free Cash Flow | 1,825,271 | 1,204,913 | 297,670 | -7,157 | 2,104,213 |